As of 3:59pm ET
| -0.18 / -6.69%|
The 1 analysts offering 12-month price forecasts for Windtree Therapeutics Inc have a median target of 35.00, with a high estimate of 35.00 and a low estimate of 35.00. The median estimate represents a +1,294.42% increase from the last price of 2.51.
The current consensus among 1 polled investment analysts is to Buy stock in Windtree Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.